Published Medical Competitive Surface Probes Scientists at Rutgers and RAD (a biotechnology start-up) have designed a way to eliminate many false positives in highly sensitive research and diagnostic technologies. By Rutgers University
Published Medical RNA Restriction Enzymes Rutgers scientists have identified and characterized 14 enzymes which recognize specific 3-, 4-, 5- and 7-base RNA sequences and cleave them at specific sites. By Rutgers University
Published Sciences Biomolecule Delivery This novel magneto-plasmonic nanoparticle technology is a versatile nanoplatform that possesses both magnetic and optical properties. By Rutgers University
Published Medical VisikolTM Rutgers scientists have identified a novel chemical solution, VisikolTM, for clearing and mounting tissues for microscopic identification. By Rutgers University
Published Medical Stem Cell Gene Expression Rutgers scientists have made possible the delivery of siRNA/DNA through utilizing extracellular matrix (ECM) proteins, such as laminin. By Rutgers University
Published Medical Effective Vein Punctuation Rutgers scientists have thus developed a novel technology that will make vein punctuation easier, more effective, and less time consuming. By Rutgers University
Published Sciences Molecular Beacons Molecular beacons provide a new tool for increasing the effectiveness and lowering the cost of clinical diagnostic assays. By Rutgers University
Published Medical Enhanced Gene Expression Rutgers scientists have developed novel gold nanoparticles (AuNPs) functionalized with synthetic transcription factor (STF) components (AuSTF). By Rutgers University
Published Medical Mesenchymal Stem Cells Rutgers investigators discovered that the ability of MSCs to “empower” other cells to facilitate tissue repair can be enhanced dramatically by certain inflammatory cytokines. By Rutgers University
Published Medical TAM Receptors Rutgers scientists have discovered a novel family of small molecule inhibitors that uniquely block TAM activation by the endogenous ligand Gas6 in the extracellular domain. By Rutgers University
Published Medical Myxopyronins Myxopyronin (Myx) is a microbially produced antibiotic that functions by inhibiting bacterial RNA polymerase through a novel binding site and novel mechanism. By Rutgers University
Published Manufacturing & Production Manufacture of Pharmaceuticals Rutgers scientists have developed a novel platform of pharmaceutical product development by utilizing fluid bed impregnation (FBI) of API solutions onto porous carriers. By Rutgers University
